Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation
- 5 October 2024
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 27 (2) , 213-221
Abstract
No abstract availableKeywords
Funding Information
- Jichi Medical University Hospital
- Jichi Medical University
- Japan Society for the Promotion of Science (JP21K07070)
This publication has 51 references indexed in Scilit:
- Associations of minor histocompatibility antigens with outcomes following allogeneic hematopoietic cell transplantationAmerican Journal of Hematology, 2023
- Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experienceAnnals of Hematology, 2020
- Optimal conditioning regimen for haplo‐identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de‐escalation study of TBI and ATG doseAmerican Journal of Hematology, 2018
- Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) studyAmerican Journal of Hematology, 2018
- Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantationInternational Journal of Hematology, 2015
- Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)International Journal of Hematology, 2015
- Degree of Predicted Minor Histocompatibility Antigen Mismatch Correlates with Poorer Clinical Outcomes in Nonmyeloablative Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2010
- Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2009
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005